Eupraxia Pharmaceuticals (NASDAQ:EPRX) Trading Down 1% – Here’s Why

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX)’s stock price fell 1% during mid-day trading on Tuesday . The stock traded as low as $3.06 and last traded at $3.06. 314 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 16,111 shares. The stock had previously closed at $3.09.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on EPRX. Rodman & Renshaw assumed coverage on shares of Eupraxia Pharmaceuticals in a research report on Thursday, November 14th. They set a “buy” rating and a $9.00 price target for the company. RODMAN&RENSHAW raised Eupraxia Pharmaceuticals to a “strong-buy” rating in a research note on Thursday, November 14th.

Eupraxia Pharmaceuticals Stock Down 1.0 %

The stock has a fifty day moving average of $3.06 and a 200-day moving average of $2.77. The stock has a market capitalization of $83.48 million and a price-to-earnings ratio of -4.25.

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company’s lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee.